THNR vs. MEDX ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Horizon Kinetics Medical ETF (MEDX)
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$25.97

Average Daily Volume

7,926

Number of Holdings *

7

* may have additional holdings in another (foreign) market
MEDX

Horizon Kinetics Medical ETF

MEDX Description The fund is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$29.38

Average Daily Volume

523

Number of Holdings *

10

* may have additional holdings in another (foreign) market
Performance
Period THNR MEDX
30 Days 2.70% 1.26%
60 Days 6.88%
90 Days -0.31%
12 Months -5.29%
4 Overlapping Holdings
Symbol Grade Weight in THNR Weight in MEDX Overlap
AMGN B 5.57% 6.05% 5.57%
LLY B 15.58% 16.22% 15.58%
MRK A 5.02% 4.96% 4.96%
PFE C 5.32% 4.37% 4.37%
Compare ETFs